Core Viewpoint - The company, Jiangsu Nuotai Aosaino Biopharmaceutical Co., Ltd., is set to hold a performance briefing for the third quarter of 2025 to discuss its operational results and financial status with investors [8][9]. Financial Data - The third quarter financial report for 2025 has been released, and it is noted that the financial statements are unaudited [3][4]. - The report includes key financial data and indicators, although specific figures are not detailed in the provided text [3]. Shareholder Information - The company has confirmed the total number of ordinary shareholders and the status of major shareholders, although specific details are not provided [5]. Investor Communication - The performance briefing will take place on October 30, 2025, from 15:00 to 16:00 at the Shanghai Stock Exchange Roadshow Center, and it will be conducted in an interactive online format [8][9]. - Investors are encouraged to submit questions in advance through the designated channels, and the company will address common concerns during the briefing [10][11]. Company Responsibility - The board of directors and senior management have assured the accuracy and completeness of the quarterly report, taking legal responsibility for its content [2][7].
江苏诺泰澳赛诺生物制药股份有限公司2025年第三季度报告